1990.9000 -13.50 (-0.67%)
NSE Sep 04, 2025 15:31 PM
Volume: 493.2K
 

Rudra Shares and Stock Brokers Ltd
GPL is primarily focused on building a global Generics, Specialty and OTC business in the therapy areas of Dermatology, Respiratory and Oncology. It also has strong regional/country specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. Has 5 US FDA approved formulation...
Deven Choksey increased Buy price target of Glenmark Pharmaceuticals Ltd. to 2300.0 on 02 Sep, 2025.
More from Glenmark Pharmaceuticals Ltd.
Recommended